Are you ready to join Connecticut Innovation’s vibrant community of innovators? Connecticut Innovations (“CI”) is Connecticut’s strategic venture capital arm, and we are passionate about serving our portfolio of 220+ companies across various industries, with strengths in life sciences, technology, and climate tech.

Come join First-in-Class Dermatology Drugs | Veradermics !

Veradermics Corporate Overview

Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions.

In October 2025, Veradermics announced the closing of an oversubscribed $150 million Series C financing with top-tier healthcare investors. The financing will enable Veradermics to advance the development of our lead candidate, VDPHL01, as an oral, non-hormo...